To clarify whether FKBP3 affected DLBCL malignant phenotype through the Wnt/β‐catenin signalling pathway, we examined changes in Wnt‐related molecules expression and DLBCL malignant phenotype. This evidence concerns the gene FKBP3 and diffuse large B-cell lymphoma.